Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cassava Sciences Inc (NQ: SAVA )

26.21 +0.41 (+1.59%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cassava Sciences Inc

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
New SAVAW Warrants Are Trading After Cassava Sciences’ Distribution
Following a distribution, investors in Cassava Sciences and SAVA stock now have some warrants to factor into their models today. 
Via InvestorPlace
Cassava Sciences Completes Dividend Distribution of Warrants to Shareholders
From Cassava Sciences, Inc.
Via GlobeNewswire
3 Growth Stocks Expected to Skyrocket in 2024, According to Wall Street
Wall Street analysts foresee up to 316% upside in three fast-paced companies in the new year. 
Via The Motley Fool
Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings. 
Via Benzinga
1 Big Red Flag to Fear When a Stock Is Down
Playing the blame game does not make for an effective turnaround strategy. 
Via The Motley Fool
Paychex Reports Downbeat Sales, Joins BlackBerry And Other Big Stocks Moving Lower On Thursday
U.S. stocks traded higher, with the Dow Jones index gaining around 200 points on Thursday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Cassava Sciences Stock Zoomed 21% Higher This Week
The company has chosen an offbeat way to keep its investors sweet. 
Via The Motley Fool
Cassava Sciences Stock Shows Rising Relative Strength Following 3 Up Days
Cassava Sciences sees its Relative Strength Rating reach the 80-plus level. 
Via Investor's Business Daily
Why Is Cassava Sciences (SAVA) Stock Up 15% Today?
Although Cassava Sciences’ issuance of warrants presents risks, the underlying Phase 3 trial support boosted SAVA stock. 
Via InvestorPlace
Blue Bird Posts Upbeat Results, Joins Oil-Dri Corporation of America, Eagle Bulk Shipping And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded higher, with the Dow Jones index gaining around 50 points on Tuesday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Cassava Sciences Stock Surged Today
Cassava Sciences, Inc. (NASDAQ: SAVA) shares are trading higher after the company announced MRI data suggested simufilam is not associated with amyloid- 
Via Benzinga
Cassava Sciences Inc. (NASDAQ: SAVA) Leading the Way in Tuesday Trading Based on Percentage Gain
Via Investor Brand Network
Cassava Sciences Announces Dividend Distribution of Warrants to Shareholders
From Cassava Sciences, Inc.
Via GlobeNewswire
What's Going On With Cassava Sciences Stock?
Cassava Sciences, Inc. (NASDAQ: SAVA) shares are trading higher Monday on continued upward momentum. The stock has gained more than 20% over than last five days. What To Know: 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
High short interest stocks: this popular trend is re-emerging
Renewed optimism has led to higher risk tolerance in stocks, which has brought back a popular trend: Stocks with high short interest are gaining popularity 
Via MarketBeat
Topics ETFs
Why Cassava Sciences Stock Soared Today
Investors cheered the arrival of a trio of new board members. 
Via The Motley Fool
Cassava Sciences Appoints Three New Members to its Board of Directors
Dr. Nicaise, Mr. Gravier and Mr. Anderson have years of experience in drug development, healthcare M&A and working with the U.S. Government 
From Cassava Sciences, Inc.
Via GlobeNewswire
7 High-Risk, High-Reward Stocks for the Extreme Contrarian
While most folks should stick on the established road, these stock picks for contrarian investors might tempt the intrepid. 
Via InvestorPlace
Cassava Sciences Reports Third Quarter 2023 Financial and Operating Results
From Cassava Sciences, Inc.
Via GlobeNewswire
Cassava Sciences Completes Enrollment for Pivotal Phase 3 Program of Simufilam in Alzheimer’s Disease
From Cassava Sciences, Inc.
Via GlobeNewswire
MRI Data Suggest Simufilam is Not Associated with Amyloid-related Imaging Abnormalities (ARIA)
From Cassava Sciences, Inc.
Via GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
7 Stocks That Are Heading for a Train Wreck
There's always a bear market somewhere. Here are seven stocks to sell that investors should definitely unload now. 
Via InvestorPlace
Why Nokia Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers 
Via Benzinga
Wyndham Hotels & Resorts, Olink Holding And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones falling around 50 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is SciSparc (SPRC) Stock Up 105% Today?
SciSparc stock is rising higher on Tuesday as shares of SPRC regain compliance with the Nasdaq minimum bid listing requirement. 
Via InvestorPlace
SAVA Stock Continues to Plunge on Misconduct Allegations
An investigation into one of Cassava Sciences' advisors is pushing shares down. Here's why investors should worry about SAVA stock. 
Via InvestorPlace
Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Sigma Additive Solutions, Inc. (NASDAQ: SASI) shares jumped 196% to $7.34 after the company announced the signing of a definitive agreement for the acquisition of NextTrip Holdings, Inc. 
Via Benzinga
Why Cassava Sciences Stock Is Tanking Today
Investors are worried about a leaked report related to alleged data manipulation for Cassava's Alzheimer's disease treatment candidate. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.